Delcath Systems Ownership
| DCTH Stock | USD 15.97 0.32 2.04% |
Shares in Circulation | First Issued 1999-09-30 | Previous Quarter 28.4 M | Current Value 32.3 M | Avarage Shares Outstanding 2.6 M | Quarterly Volatility 6.1 M |
Delcath |
Delcath Stock Ownership Analysis
About 38.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.17. Delcath Systems last dividend was issued on the 24th of December 2019. The entity had 1:700 split on the 24th of December 2019. Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Delcath Systems operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people. To learn more about Delcath Systems call MS MBA at 212 489 2100 or check out https://www.delcath.com.Besides selling stocks to institutional investors, Delcath Systems also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Delcath Systems' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Delcath Systems' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Delcath Systems Quarterly Liabilities And Stockholders Equity |
|
Delcath Systems Insider Trades History
Roughly 3.0% of Delcath Systems are currently held by insiders. Unlike Delcath Systems' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Delcath Systems' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Delcath Systems' insider trades
Delcath Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Delcath Systems is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Delcath Systems backward and forwards among themselves. Delcath Systems' institutional investor refers to the entity that pools money to purchase Delcath Systems' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citadel Advisors Llc | 2024-09-30 | 154 K | Kennedy Capital Management Inc | 2024-09-30 | 136.5 K | Legato Capital Management Llc | 2024-09-30 | 115.5 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 106.5 K | Ikarian Capital, Llc | 2024-09-30 | 100.4 K | Blackrock Inc | 2024-09-30 | 99.2 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 90.9 K | Principal Financial Group Inc | 2024-09-30 | 89.4 K | Eam Investors, Llc | 2024-09-30 | 88.2 K | Rosalind Advisors, Inc. | 2024-09-30 | 2.7 M | Aigh Capital Management, Llc | 2024-09-30 | 1.8 M |
Delcath Systems Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Delcath Systems insiders, such as employees or executives, is commonly permitted as long as it does not rely on Delcath Systems' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Delcath Systems insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Delcath Systems Outstanding Bonds
Delcath Systems issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Delcath Systems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Delcath bonds can be classified according to their maturity, which is the date when Delcath Systems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US24665FAC68 Corp BondUS24665FAC68 | View | |
| DELHAIZE GROUP SA Corp BondUS24668PAE79 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Delcath Systems Corporate Filings
| 27th of January 2025 Other Reports | ViewVerify | |
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 27th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Delcath Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Delcath Systems' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Delcath Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Delcath Systems Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Delcath Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Delcath Systems. If investors know Delcath will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Delcath Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share | Quarterly Revenue Growth 14.689 | Return On Assets | Return On Equity |
The market value of Delcath Systems is measured differently than its book value, which is the value of Delcath that is recorded on the company's balance sheet. Investors also form their own opinion of Delcath Systems' value that differs from its market value or its book value, called intrinsic value, which is Delcath Systems' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Delcath Systems' market value can be influenced by many factors that don't directly affect Delcath Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Delcath Systems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Delcath Systems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Delcath Systems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.